Acne/HS/RosaceaPoster 1The role of oral antibiotics in the treatment of mild to moderate hidradenitis suppurativa
Acne/HS/RosaceaPoster 2An Updated Reference for Empiric Antibiotic Therapy in Hidradenitis Suppurativa
Acne/HS/RosaceaPoster 3Efficacy and Safety of a Fixed-Dose Clindamycin 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: Randomized
Acne/HS/RosaceaPoster 4Tazarotene 0.045% Lotion for Truncal Acne: Efficacy, Tolerability, and Spreadability
Acne/HS/RosaceaPoster 5Efficacy of 1% clascoterone cream through up to 12 months from a long-term extension study in patients ≥9 years of age with acne vulgaris
Acne/HS/RosaceaPoster 7Critical Evaluation of Benzoyl Peroxide in Rosacea: Old Challenges and New Clinical Opportunities With Encapsulated Benzoyl Peroxide
Acne/HS/RosaceaPoster 8Encapsulated benzoyl peroxide (E-BPO): A novel formulation of BPO for long-term management of rosacea
Atopic DermatitisPoster 10Tapinarof Cream 1% Once Daily for the Treatment of Moderate to Severe Atopic Dermatitis in Children and Adults: The Pivotal Phase 3 ADORING
Atopic DermatitisPoster 11Racial and Ethnic Differences in Sociodemographic and Treatment Characteristics Among Patients with Atopic Dermatitis in the United States:
Atopic DermatitisPoster 12Efficacy and Safety of Lebrikizumab in Moderate-to-Severe Atopic Dermatitis: Results from Two Phase 3, Randomized, Double-Blinded, Placebo-C
Atopic DermatitisPoster 13Efficacy and Safety of Lebrikizumab in Combination with Topical Corticosteroids in Patients with Moderate-to-Severe Atopic Dermatitis...
Atopic DermatitisPoster 14Post-hoc Analyses of Lebrikizumab Phase 3 Trials (LAVOLTA I and II): Enhanced Efficacy in Patients with Prior Exacerbations and Elevated...
Atopic DermatitisPoster 15Lebrikizumab Allows Interleukin (IL)-13 Membrane Binding and Subsequent Internalization through IL-13 Receptor Alpha 2 (Ra2) [IL-13 decoy...